Alzheimer’s Disease Medications Newly Approved By FDA
The U.S. Food and Drug Administration (FDA) has approved two types of New Alzheimer’s Disease Medications, cholinesterase inhibitors (Aricept, Exelon, Razadyne) and memantine (Namenda) — to treat the cognitive symptoms (memory loss, confusion, and problems with thinking and reasoning) of Alzheimer’s disease. There is also a medication that compound one of the cholinesterase inhibitors (donepezil) with memantine called Namzaric.
As Alzheimer’s disease progresses, brain cells die and connections between cells are lost, causing cognitive symptoms to worsen. While current Alzheimer’s Disease Medications cannot stop the damage Alzheimer’s causes to brain cells, they may help reduce or stabilize symptoms for a limited time by affecting certain chemicals involved in carrying messages among the brain’s nerve cells. Doctors sometimes prescribe both types of new Alzheimer’s Disease Medications together.